SynCardia Certified Centers Perform Record Number of Total Artificial Heart Implants During Q1 2013

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that a record 40 implants of the SynCardia temporary Total Artificial Heart were performed at 24 SynCardia Certified Centers during the quarter ended March 31, 2013.

“By April 16, we surpassed 50 implants of the Total Artificial Heart performed this year,” said Michael Garippa, SynCardia Chairman/CEO/President. “If SynCardia Certified Centers continue to implant at this rate, for the first time in company history, more than 160 implants of the Total Artificial Heart will be performed this year.”

In March, the 500th implant of the Total Artificial Heart in the U.S. was performed, with the total number of implants now surpassing 1,150 worldwide. There are currently 80 SynCardia Certified Centers worldwide with an additional 36 hospitals undergoing SynCardia’s four-phase certification program… read more